Cargando…

High-flow nasal cannula therapy, factors affecting effective inspired oxygen fraction: an experimental adult bench model

Oxygenation through High Flow Delivery Systems (HFO) is described as capable of delivering accurate F(iO2). Meanwhile, peak inspiratory flow [Formula: see text] ) of patients with acute hypoxemic respiratory failure can reach up to 120 L/min, largely exceeding HFO flow. Currently, very few data on t...

Descripción completa

Detalles Bibliográficos
Autores principales: Duprez, Frédéric, de Terwangne, C., Bellemans, V., Poncin, W., Reychler, G., Sorgente, A., Cuvelier, G., Mashayekhi, S., Wittebole, X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651462/
https://www.ncbi.nlm.nih.gov/pubmed/34877626
http://dx.doi.org/10.1007/s10877-021-00784-z
_version_ 1784611401411592192
author Duprez, Frédéric
de Terwangne, C.
Bellemans, V.
Poncin, W.
Reychler, G.
Sorgente, A.
Cuvelier, G.
Mashayekhi, S.
Wittebole, X.
author_facet Duprez, Frédéric
de Terwangne, C.
Bellemans, V.
Poncin, W.
Reychler, G.
Sorgente, A.
Cuvelier, G.
Mashayekhi, S.
Wittebole, X.
author_sort Duprez, Frédéric
collection PubMed
description Oxygenation through High Flow Delivery Systems (HFO) is described as capable of delivering accurate F(iO2). Meanwhile, peak inspiratory flow [Formula: see text] ) of patients with acute hypoxemic respiratory failure can reach up to 120 L/min, largely exceeding HFO flow. Currently, very few data on the reliability of HFO devices at these high [Formula: see text] are available. We sought to evaluate factors affecting oxygenation while using HFO systems at high [Formula: see text] in a bench study. Spontaneous breathing was generated with a mechanical test lung connected to a mechanical ventilator Servo-i®, set to volume control mode. Gas flow from a HFO device was delivered to the test lung. The influence on effective inspired oxygen fraction of three parameters (F(iO2) 0.6, 0.8, and 1, [Formula: see text] from 28 to 98.1 L/min, and HFO Gas Flows from 40 to 60 L/min) were analyzed and are reported. The present bench study demonstrates that during HFO treatment, measured F(iO2) in the lung does not equal set F(iO2) on the device. The substance of this variation (ΔF(iO2)) is tightly correlated to [Formula: see text] (Pearson’s coefficient of 0.94, p-value < 0.001). Additionally, set F(iO2) and Flow at HFO device appear to significatively affect ΔF(iO2) as well (p-values < 0.001, adjusted to [Formula: see text] ). The result of multivariate linear regression indicates predictors ([Formula: see text] , Flow and set F(iO2)) to explain 92% of the variance of delta F(iO2) through K-Fold Cross Validation. Moreover, adjunction of a dead space in the breathing circuit significantly decreased ΔF(iO2) (p < 0.01). The present bench study did expose a weakness of HFO devices in reliability of delivering accurate F(IO2) at high [Formula: see text] as well as, to a lesser extent, at [Formula: see text] below equivalent set HFO Flows. Moreover, set HFO flow and set F(IO2) did influence the variability of effective inspired oxygen fraction. The adjunction of a dead space in the experimental set-up significantly amended this variability and should thus be further studied in order to improve success rate of HFO therapy.
format Online
Article
Text
id pubmed-8651462
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-86514622021-12-08 High-flow nasal cannula therapy, factors affecting effective inspired oxygen fraction: an experimental adult bench model Duprez, Frédéric de Terwangne, C. Bellemans, V. Poncin, W. Reychler, G. Sorgente, A. Cuvelier, G. Mashayekhi, S. Wittebole, X. J Clin Monit Comput Original Research Oxygenation through High Flow Delivery Systems (HFO) is described as capable of delivering accurate F(iO2). Meanwhile, peak inspiratory flow [Formula: see text] ) of patients with acute hypoxemic respiratory failure can reach up to 120 L/min, largely exceeding HFO flow. Currently, very few data on the reliability of HFO devices at these high [Formula: see text] are available. We sought to evaluate factors affecting oxygenation while using HFO systems at high [Formula: see text] in a bench study. Spontaneous breathing was generated with a mechanical test lung connected to a mechanical ventilator Servo-i®, set to volume control mode. Gas flow from a HFO device was delivered to the test lung. The influence on effective inspired oxygen fraction of three parameters (F(iO2) 0.6, 0.8, and 1, [Formula: see text] from 28 to 98.1 L/min, and HFO Gas Flows from 40 to 60 L/min) were analyzed and are reported. The present bench study demonstrates that during HFO treatment, measured F(iO2) in the lung does not equal set F(iO2) on the device. The substance of this variation (ΔF(iO2)) is tightly correlated to [Formula: see text] (Pearson’s coefficient of 0.94, p-value < 0.001). Additionally, set F(iO2) and Flow at HFO device appear to significatively affect ΔF(iO2) as well (p-values < 0.001, adjusted to [Formula: see text] ). The result of multivariate linear regression indicates predictors ([Formula: see text] , Flow and set F(iO2)) to explain 92% of the variance of delta F(iO2) through K-Fold Cross Validation. Moreover, adjunction of a dead space in the breathing circuit significantly decreased ΔF(iO2) (p < 0.01). The present bench study did expose a weakness of HFO devices in reliability of delivering accurate F(IO2) at high [Formula: see text] as well as, to a lesser extent, at [Formula: see text] below equivalent set HFO Flows. Moreover, set HFO flow and set F(IO2) did influence the variability of effective inspired oxygen fraction. The adjunction of a dead space in the experimental set-up significantly amended this variability and should thus be further studied in order to improve success rate of HFO therapy. Springer Netherlands 2021-12-08 2022 /pmc/articles/PMC8651462/ /pubmed/34877626 http://dx.doi.org/10.1007/s10877-021-00784-z Text en © The Author(s), under exclusive licence to Springer Nature B.V. 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Research
Duprez, Frédéric
de Terwangne, C.
Bellemans, V.
Poncin, W.
Reychler, G.
Sorgente, A.
Cuvelier, G.
Mashayekhi, S.
Wittebole, X.
High-flow nasal cannula therapy, factors affecting effective inspired oxygen fraction: an experimental adult bench model
title High-flow nasal cannula therapy, factors affecting effective inspired oxygen fraction: an experimental adult bench model
title_full High-flow nasal cannula therapy, factors affecting effective inspired oxygen fraction: an experimental adult bench model
title_fullStr High-flow nasal cannula therapy, factors affecting effective inspired oxygen fraction: an experimental adult bench model
title_full_unstemmed High-flow nasal cannula therapy, factors affecting effective inspired oxygen fraction: an experimental adult bench model
title_short High-flow nasal cannula therapy, factors affecting effective inspired oxygen fraction: an experimental adult bench model
title_sort high-flow nasal cannula therapy, factors affecting effective inspired oxygen fraction: an experimental adult bench model
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651462/
https://www.ncbi.nlm.nih.gov/pubmed/34877626
http://dx.doi.org/10.1007/s10877-021-00784-z
work_keys_str_mv AT duprezfrederic highflownasalcannulatherapyfactorsaffectingeffectiveinspiredoxygenfractionanexperimentaladultbenchmodel
AT deterwangnec highflownasalcannulatherapyfactorsaffectingeffectiveinspiredoxygenfractionanexperimentaladultbenchmodel
AT bellemansv highflownasalcannulatherapyfactorsaffectingeffectiveinspiredoxygenfractionanexperimentaladultbenchmodel
AT poncinw highflownasalcannulatherapyfactorsaffectingeffectiveinspiredoxygenfractionanexperimentaladultbenchmodel
AT reychlerg highflownasalcannulatherapyfactorsaffectingeffectiveinspiredoxygenfractionanexperimentaladultbenchmodel
AT sorgentea highflownasalcannulatherapyfactorsaffectingeffectiveinspiredoxygenfractionanexperimentaladultbenchmodel
AT cuvelierg highflownasalcannulatherapyfactorsaffectingeffectiveinspiredoxygenfractionanexperimentaladultbenchmodel
AT mashayekhis highflownasalcannulatherapyfactorsaffectingeffectiveinspiredoxygenfractionanexperimentaladultbenchmodel
AT wittebolex highflownasalcannulatherapyfactorsaffectingeffectiveinspiredoxygenfractionanexperimentaladultbenchmodel